These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 19062007

  • 1. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ.
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [Abstract] [Full Text] [Related]

  • 2. Dietary therapy in polycystic ovary syndrome.
    Moran LJ, Brinkworth GD, Norman RJ.
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [Abstract] [Full Text] [Related]

  • 3. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL, Buckley JD, Brinkworth GD.
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [Abstract] [Full Text] [Related]

  • 4. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [Abstract] [Full Text] [Related]

  • 5. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 6. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 7. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    Fertil Steril; 2010 Oct; 94(5):1812-6. PubMed ID: 20004371
    [Abstract] [Full Text] [Related]

  • 8. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM.
    Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 11. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF.
    Arch Intern Med; 2006 Oct 23; 166(19):2081-6. PubMed ID: 17060537
    [Abstract] [Full Text] [Related]

  • 13. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun 23; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 14. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.
    BJOG; 2006 Oct 23; 113(10):1210-7. PubMed ID: 16972863
    [Abstract] [Full Text] [Related]

  • 15. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.
    Minerva Endocrinol; 2007 Sep 23; 32(3):129-40. PubMed ID: 17912153
    [Abstract] [Full Text] [Related]

  • 16. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan 23; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB.
    Hum Reprod; 2008 Jun 23; 23(6):1431-8. PubMed ID: 18359783
    [Abstract] [Full Text] [Related]

  • 18. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
    Fertil Steril; 2008 Mar 23; 89(3):505-22. PubMed ID: 18243179
    [Abstract] [Full Text] [Related]

  • 19. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E.
    Minerva Ginecol; 2006 Apr 23; 58(2):109-14. PubMed ID: 16582867
    [Abstract] [Full Text] [Related]

  • 20. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM.
    Semin Reprod Med; 2008 Jan 23; 26(1):93-100. PubMed ID: 18181087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.